B5- Dolph Chianchiano.2.ppt

  • 201 views
Uploaded on

 

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
201
On Slideshare
0
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
0
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide
  • Read aloud, and comment if desired.
  • The components titled on the following pages provide the participants with the knowledge to change practice behaviors and leverage better patient outcomes. A protocol allows patients to timely identify CKD and diabetes using easy, available and cost-efficient tests. Pharmacologic guidance allows clinicians to understand and choose the best therapy. Finally, two case studies managed by CKD/diabetes care teams allow participants to learn how to apply the protocol tests and phamacologic guidance, and timely treat.
  • Read aloud, and comment if desired.
  • Read aloud, and comment if desired.

Transcript

  • 1. Improving Patient Outcomes in Chronic Kidney Disease in Diabetes via Multiple Educational Formats
    • A collaboration between the National Kidney
    • Foundation and the Diabetes
    • Prevention and Control Program (DPCP)
    • New York State Department of Health
    • Fall, 2006-December, 2007
    • Session: B5-25664 Dolph Chianchiano
  • 2. Rationale
    • Rationale
    • The National Kidney Foundation (NKF)
    • learned that many primary care clinicians
    • were not routinely screening for both
    • chronic kidney disease (CKD) and diabetes;
    • co-morbid diseases that adversely impact
    • patient outcomes. NKF wanted to increase
    • early intervention to improve patient
    • outcomes and felt this goal could be
    • reached by offering continuing education to
    • primary care clinicians.
  • 3. Rationale Cross-sectional analysis of tests at a regional Lab Corp facility, April1, 2002, through March 31, 2003.
  • 4. Rationale
    • Random National Sample of Nephrologists, Family Physicians, and General Internists
  • 5. Objective
    • Objective
    • In response to the growing prevalence
    • of co-morbid CKD and diabetes, the need
    • to screen for both these diseases during
    • patient encounters, and the recent release
    • of NKF’s “Clinical Practice Guidelines and
    • Recommendations for Chronic
    • Kidney Disease and Diabetes,” educate
    • clinicians on timely identification and
    • treatment strategies via multiple
    • educational formats and delivery
    • methodologies.
  • 6. Partners
    • Partners
    • National Kidney Foundation’s national office and New York state affiliates
    • New York State Department of Health’s Diabetes Prevention and Control Program (DPCP)
    • New York state Community Diabetes Coalitions
  • 7. Process
    • Process to Develop and Deliver Programs
    • Conduct needs assessment and evaluate data from clinicians and NKF’s KEEP screening program to drive learning objectives and content
    • Identify target audience likely to impact patients: selected primary care physicians, nurses, pharmacists, and dietitians, all members of a CKD and diabetes care team
    • Identify learning objectives with outcomes that can change clinical practice
  • 8. Select Education Delivery Modes
    • Based on Adult Learning Principles, select formats for delivering continuing education:
      • Live symposium using slides and case studies to invite dialogue and interaction
      • Audio/video teleconferencing delivery to rural areas to extend reach and accessibility to learning
      • “Team-teaching” by faculty: nephrologist and primary care or endocrinologist to model desired team behaviors in the clinical setting
      • Support learning with “CKD Pack” of printed materials for clinicians and patients for use after the live program.
  • 9. Process (cont’d)
    • Process (cont.)
    • Select sites
      • Local affiliates collaborate with hospitals that support symposia for clinical education
    • Recruit workgroup for content development
      • Utilized five national experts on CKD, diabetes, pharmacy, dietetics, and primary care for integrated approach
    • Develop content - included:
      • an easy and cost-efficient protocol for timely identification;
      • pharmacologic guidance for practical implementation;
      • case studies to illustrate timely treatment using a team approach.
  • 10. Process (cont.)
    • Process (cont.)
    • Recruit and train faculty
      • recruited local faculty considered knowledgeable, good teachers and speakers
      • each faculty consisted of a nephrologist and endocrinologist to model collaboration skills
    • Design participant educational packet to extend learning:
      • Patient education resources from NKF inventory for the office and to support patient teaching
      • Professional education resources on GFR, CKD and Diabetes
    • Design participant and faculty program manuals
      • Printed handout with program agenda and slides
  • 11. Process (cont.)
    • Process (cont.)
    • Create promotion and marketing plan
      • Designate symposium as a “Grand Rounds” to signify its importance and encourage attendance
      • Sent email blitzes to potential participants,
      • Provided posters for hospital sites and local marketing materials for affiliates to distribute
    • Facilitate continuing education credits
      • Provide CME and CE credits for multiple disciplines to encourage attendance.
    • Evaluate participant and faculty feedback
      • Used Scantron evaluation forms for ease of processing
      • Analyze results for strengths and areas of improvement for future programs
  • 12.  
  • 13. Learning Objectives
    • State the public health significance of the CKD and diabetes prevalence in New York State, the U.S. and around the world
    • Describe the use of eGFR (estimated Glomerular Filtration Rate) and other methods for timely identification of CKD in diabetes
    • Discuss the management of CKD in diabetes using timely behavioral, nutritional and medical interventions to improve patient outcomes
  • 14.
    • Three Key Program Components
  • 15.
    • Easy and cost-efficient protocol for
    • timely identification
    • of CKD in diabetes *
    • *also referred to as Diabetic Kidney Disease (DKD)
  • 16. Pharmacologic Guidance Recommended Dosing and Dosing Adjustments for Drugs Used to Achieve Glycemic Control in CKD Stages 3 and 4* * NKF’s KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease (AJKD, 2007), www.kdoqi.org
  • 17. Two Case Study Illustrating Timely Treatment of CKD in Diabetes Through Medical, Behavioral, and Nutritional Team Management
  • 18. Outcomes
    • Outcomes
    • Three-hundred and forty clinicians attended
    • the symposium statewide:
    • 98% indicated satisfaction with the program
    • 95% said they gained new knowledge
    • 85% said they would make changes in their practice
    • 99% said they would recommend the program to their peers.
  • 19. Conclusion
    • Conclusions
    • Educating clinicians about urgent public
    • health needs, in multiple educational formats
    • and delivery methodologies, are
    • effective means for increasing clinician
    • awareness and enhancing quality of care
    • NKF hopes to take the Grand Rounds
    • symposium to additional sites in New York state
  • 20.
    • Questions